Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Jan 17;12(2):e026469.
doi: 10.1161/JAHA.122.026469. Epub 2023 Jan 11.

Evidence of Carotid Atherosclerosis Vulnerability Regression in Real Life From Magnetic Resonance Imaging: Results of the MAGNETIC Prospective Study

Affiliations
Observational Study

Evidence of Carotid Atherosclerosis Vulnerability Regression in Real Life From Magnetic Resonance Imaging: Results of the MAGNETIC Prospective Study

Oronzo Catalano et al. J Am Heart Assoc. .

Abstract

Background Atherosclerosis vulnerability regression has been evidenced mostly in randomized clinical trials with intensive lipid-lowering therapy. We aimed to demonstrate vulnerability regression in real life, with a comprehensive quantitative method, in patients with asymptomatic mild to moderate carotid atherosclerosis on a secondary prevention program. Methods and Results We conducted a single-center prospective observational study (MAGNETIC [Magnetic Resonance Imaging as a Gold Standard for Noninvasive Evaluation of Atherosclerotic Involvement of Carotid Arteries]): 260 patients enrolled at a cardiac rehabilitation center were followed for 3 years with serial magnetic resonance imaging. Per section cutoffs (95th/5th percentiles) were derived from a sample of 20 consecutive magnetic resonance imaging scans: (1) lipid-rich necrotic core: 26% of vessel wall area; (2) intraplaque hemorrhage: 12% of vessel wall area; and (3) fibrous cap: (a) minimum thickness: 0.06 mm, (b) mean thickness: 0.4 mm, (c) projection length: 11 mm. Patients with baseline magnetic resonance imaging of adequate quality (n=247) were classified as high (n=63, 26%), intermediate (n=65, 26%), or low risk (n=119, 48%), if vulnerability criteria were fulfilled in ≥2 contiguous sections, in 1 or multiple noncontiguous sections, or in any section, respectively. Among high-risk patients, a conversion to any lower-risk status was found in 11 (17%; P=0.614) at 6 months, in 16 (25%; P=0.197) at 1 year, and in 19 (30%; P=0.009) at 3 years. Among patients showing any degree of carotid plaque vulnerability, 21 (16%; P=0.014) were diagnosed at low risk at 3 years. Conclusions This study demonstrates with a quantitative approach that vulnerability regression is common in real life. A secondary prevention program can promote vulnerability regression in asymptomatic patients in the mid to long term.

Keywords: cardiac rehabilitation; carotid atherosclerosis; magnetic resonance imaging; modifiable risk factors; secondary prevention; vulnerability regression.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Regression of carotid plaque vulnerability during the study in patients who at baseline were at high risk (A), and at intermediate or high risk (B).
*Vulnerability risk of atherosclerosis defined by the quantitative assessment of the lipid‐rich necrotic core, the fibrous cap, and intraplaque hemorrhage. HR indicates high risk; IR, intermediate risk; and LR, low risk.
Figure 2
Figure 2. Examples of highly vulnerable plaques at baseline with favorable evolution at end of study.
Figure 3
Figure 3. Kaplan–Meier survival curves (all‐cause death) of patients with vulnerable carotid plaques (high or intermediate risk) and patients with stable atherosclerosis at baseline.

References

    1. Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, Cote R, Hess SDJ, Spence JD, et al. Carotid endarterectomy—an evidence‐based review: report of the therapeutics and technology assessment Subcommittee of the American Academy of neurology. Neurology. 2005;65:794–801. doi: 10.1212/01.wnl.0000176036.07558.82 - DOI - PubMed
    1. North American Symptomatic Carotid Endarterectomy Trial Collaborators , Barnett HJM, Taylor DW, Haynes RB, Sackett DL, Peerless SJ, Ferguson GG, Fox AJ, Rankin RN, Hachinski VC, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high‐grade carotid stenosis. N Engl J Med. 1991;325:445–453. doi: 10.1056/NEJM199108153250701 - DOI - PubMed
    1. Endarterectomy for asymptomatic carotid artery stenosis . Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273:1421–1428. - PubMed
    1. Warlow C. MRC European carotid surgery trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet. 1991;337:1235–1243. doi: 10.1016/0140-6736(91)92916-P - DOI - PubMed
    1. Rothwell PM, Gutnikov SA, Warlow CP; European carotid surgery Trialist's collaboration . Reanalysis of the final results of the European carotid surgery trial. Stroke. 2003;34:514–523. doi: 10.1161/01.STR.0000054671.71777.C7 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources